Sareum Holdings (SAR)
market vs.
industry GROWTH & VALUE
| Trailing 12m | ||||
| PE Ratio (ttm) | n/a |
|
|
|
| PEG Ratio (ttm) |
|
|
||
| EPS Growth (ttm) | % |
|
|
|
| Dividend Yield (ttm) | % |
|
|
|
| Valuation (ttm) | ||||
| Price to Book Value | 37.8 |
|
|
|
| Price to Tang. Book |
|
|
||
| Price to Free Cashflow |
|
|
||
| Price to Sales |
|
|
||
| EV to EBITDA |
|
|
||
market vs.
industry QUALITY
| Year End 30th Jun | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | TTM | 2013E | 2014E | CAGR / Avg | |
| Revenue | £m | ||||||||||
| Operating Profit | £m | ||||||||||
| Net Profit | £m | ||||||||||
| EPS Reported | p | ||||||||||
| EPS Normalised | p | ||||||||||
| EPS Growth | % | ||||||||||
| PE Ratio | x | ||||||||||
| PEG | x | ||||||||||
| Profitability | |||||||||||
| Operating Margin | % | ||||||||||
| ROA | % | ||||||||||
| ROCE | % | ||||||||||
| ROE | % | ||||||||||
| Cashflow | |||||||||||
| Op. Cashflow ps | p | ||||||||||
| Capex ps | p | ||||||||||
| Free Cashflow ps | p | ||||||||||
| Dividends | |||||||||||
| Dividend ps | p | ||||||||||
| Dividend Growth | % | ||||||||||
| Dividend Yield | % | ||||||||||
| Dividend Cover | x | ||||||||||
| Balance Sheet | |||||||||||
| Cash etc | £m | ||||||||||
| Working Capital | £m | ||||||||||
| Net Fixed Assets | £m | ||||||||||
| Net Debt | £m | ||||||||||
| Book Value | £m | ||||||||||
| Average Shares | m | ||||||||||
| Book Value ps | p | -35.8% | |||||||||
FINANCIAL BRIEF: For the six months ended 31 December 2012, Sareum Holdings Plc revenues was not reported. Net loss decreased 18% to L269K. Lower net loss reflects Operating Expenses - Continued Operation decrease of 16% to L305K (expense). more »
| Leverage (ttm) | Total | Ex Intang | |||
| Gross Gearing | % | ||||
| Net Gearing | % | ||||
| Cash / Assets | % | ||||
| Liquidity (ttm) | ||
| Current Ratio | ||
| Quick Ratio | ||
| Interest Cover | ||
| Efficiency (ttm) | ||
| Asset Turnover | ||
| Rec's Turnover | ||
| Stock Turnover | ||
market vs.
industry RECENT HISTORY
| Latest interim period (ended 31st Dec '12) vs. prior year | ||||
| Sales Growth | % |
|
|
|
| EPS Growth | % |
|
|
|
| 3yr Average Annualised | ||||
| Sales Growth | % |
|
|
|
| EPS Growth | % |
|
|
|
| DPS Growth | % |
|
|
|
BROKER CONSENSUS & FORECAST TREND
| Recommendation: | Strong Sell | Sell | Hold | Buy | Strong Buy |
|---|---|---|---|---|---|
| No. of Analysts: |
Sareum Holdings plc (Sareum) is a United Kingdom-based holding company. The Company is a cancer drug discovery company. The Company, along with its subsidiaries, is engaged in the discovery and development of new therapeutic drugs by a combination of skills in biology, computational chemistry and medicinal chemistry. The Company focuses on developing therapies for cancer and auto-immune diseases. In August 2011, the most promising lead molecule from this programme was declared a candidate for pre-clinical development. Sareum Kinase Inhibitor Library (SKIL) is Sareum’s drug discovery technology platform that has produced the Company’s Aurora, VEGFR-3, ALK, FLT3 & TYK2 kinase cancer and auto-immune disease research programmes. SKIL can also generate drug research programmes against additional kinase and other targets.
Directors: Tim Mitchell (CEO) 52, John Reader (CSO) 45, Tony Bunn (Secy.) ,
No. of Employees: 2 No. of Shareholders: n/a
| Last Annual | June 30th, 2012 |
| Last Interim | December 31st, 2012 |
| Shares in Issue | 1,521,538,263 |
| Free Float | 1.36bn (89.3%) |
| Sector | Healthcare |
| Industry | Biotechnology & Medical Research |
| Index | FTSE Aim All Share, |
| Exchange |
London Stock Exchange (AIM) |
| Eligible for | an ISA? a SIPP? |
| Address | Unit 2a,Langford Arch London Road Pampisford, CAMBRIDGE, CB22 3FX, United Kingdom |
| Web | http://www.sareum.co.uk/ |
| Phone | +44 1223 497700 |
| Contact | () |
| Registrar | Capita Registrars |
| Auditors | Shipleys LLP |
| 24th Apr | Statement re Grant Award |
| 22nd Apr | Co-devlopment Agreement |
| 25th Mar | SAREUM HOLDINGS PLC : Issue of Equity |
| 19th Mar | SAREUM HOLDINGS PLC : Adviser Change of Name |
| 18th Feb | SAREUM HOLDINGS PLC : Research Update |
| 18th Feb | Half-yearly report |
Recent ↓
